Untangling the Granulomatous Web of Sarcoidosis

Moderator(s)

• 

  Teresa Tarrant, MD

  Duke University
  Durham, NC, United States

  Disclosure(s): Amgen: Grant/Research Support (Ongoing); Chiesi: Consultant (Ongoing), Grant/Research Support (Ongoing); Department of Justice: Consultant (Ongoing); X4 Pharmaceuticals: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)
• 

  Matthew Baker, MD,MS

  Stanford University
  Menlo Park, California, United States

  Disclosure(s): Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); AnaptysBio: Consultant (Ongoing); Annexon Biosciences: Consultant (Ongoing); argenx: Consultant (Ongoing); BeiGene: Grant/Research Support (Ongoing); EBVio Inc.: Consultant (Ongoing), Equity interest (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Flatiron Bio, LLC: Consultant (Ongoing), Equity interest (Ongoing); Gilead: Consultant (Ongoing), Grant/Research Support (Ongoing); Halia Therapeutics: Consultant (Ongoing); Kiniksa Pharmaceuticals: Consultant (Ongoing), Grant/Research Support (Ongoing); Neurocrine: Consultant (Ongoing); Ouro Medicines: Consultant (Ongoing), Equity interest (Ongoing); Progentec Diagnostics: Consultant (Ongoing); Sanofi: Consultant (Ongoing), Grant/Research Support (Ongoing); Shoreline Biosciences: Consultant (Ongoing); Zenas BioPharma: Consultant (Ongoing), Grant/Research Support (Ongoing)

Session Coordinator(s)

• 

  Teresa Tarrant, MD

  Duke University
  Durham, NC, United States

  Disclosure(s): Amgen: Grant/Research Support (Ongoing); Chiesi: Consultant (Ongoing), Grant/Research Support (Ongoing); Department of Justice: Consultant (Ongoing); X4 Pharmaceuticals: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)

Sarcoidosis is a multifaceted systemic disease with wide ranging clinical presentations. The goals of this session are to better understand sarcoidosis phenotypes and granuloma formation through the lens of sex and genetic ancestry. This session will also discuss emerging sarcoidosis models to better understand disease pathogenesis and identify future therapeutic targets.

Presentations:

• 2:30 PM – 3:00 PM Central Time

  New Advances in Sarcoidosis Models and Implications for Therapeutic Discovery
  

  Speaker: Daniel Culver – Cleveland Clnic
• 3:00 PM – 3:30 PM Central Time

  The Genetics of Sarcoidosis as Seen Through the Prism of Sex, Ancestry, and Phenotype
  

  Speaker: Courtney Montgomery, PhD – Oklahoma Medical Research Foundation